Essential Hypertension
📧 Sign up to get email alerts when something new happens for Essential Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-11-04Clinical Trial Update: A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male Volunteers [Phase 1]
Phase 1 study evaluating the effect of fimasartan on the pharmacokinetics and safety of digoxin in healthy male volunteers.
-
CLINICAL_TRIALS trial_result · 2009-11-04Clinical Trial Update: Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers [Phase 1]
Phase 1 study evaluating safety and pharmacokinetics of oral fimasartan in healthy elderly and young male volunteers has completed. The stud…
-
CLINICAL_TRIALS trial_result · 2009-10-08Clinical Trial Update: A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male Volunteers [Phase 1]
This Phase 1 trial update reports a completed pharmacokinetic interaction study to evaluate whether co-administration of fimasartan and amlo…
-
CLINICAL_TRIALS trial_result · 2009-10-08Clinical Trial Update: A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers [Phase 1]
A Phase 1 PK interaction study assessed whether atorvastatin affects the pharmacokinetics of fimasartan in healthy male volunteers to evalua…
-
CLINICAL_TRIALS trial_result · 2009-10-08Clinical Trial Update: A Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers [Phase 1]
Phase 1 study evaluating the effect of ketoconazole and rifampicin on the pharmacokinetics of fimasartan in healthy volunteers; the trial ha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-10-08Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers [Phase 1]
Phase 1 study evaluating the safety and pharmacokinetics of co-administered fimasartan and hydrochlorothiazide in healthy male volunteers.
-
CLINICAL_TRIALS trial_result · 2009-10-08Clinical Trial Update: A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers [Phase 1]
A Phase 1 trial assessing the pharmacodynamics, pharmacokinetics, and safety of fimarsartan when co-administered with warfarin in healthy ma…
-
CLINICAL_TRIALS trial_result · 2009-07-23Clinical Trial Update: Olmesartan Medoxomil Versus Losartan in Patients With Hypertension [Phase 3]
Phase 3 trial comparing olmesartan medoxomil with losartan in adults with essential hypertension has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2009-07-20Clinical Trial Update: Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of combining amlodipine and losartan in patients with essential hypertension has c…
-
CLINICAL_TRIALS trial_result · 2009-07-16Clinical Trial Update: Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension [Phase 3]
A Phase 3 trial comparing amlodipine plus losartan versus losartan alone in essential hypertension has completed, evaluating the efficacy an…
-
CLINICAL_TRIALS trial_result · 2009-07-13Clinical Trial Update: Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K) [Phase 2]
Phase 2 clinical trial update evaluating the efficacy, safety, and PK/PD of fimasartan (BR-A-657•K) in adults with essential hypertension.
-
CLINICAL_TRIALS trial_result · 2009-06-18Clinical Trial Update: Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients [Phase 2]
A Phase 2 clinical trial completed to assess the efficacy and tolerability of fimasartan in mild-to-moderate essential hypertension and to d…
-
CLINICAL_TRIALS trial_result · 2009-06-17Clinical Trial Update: Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension [Phase 3]
A Phase 3 clinical trial update on the combination of olmesartan and hydrochlorothiazide for essential hypertension has completed with resul…
-
CLINICAL_TRIALS trial_result · 2009-04-30Clinical Trial Update: Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension [Phase 4]
Phase 4 study update assessing the efficacy and safety of olmesartan medoxomil for stage 1 and stage 2 essential hypertension. Results were …
-
CLINICAL_TRIALS trial_result · 2009-04-20Clinical Trial Update: Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension [Phase 3]
Phase 3 trial update on the combination of olmesartan and hydrochlorothiazide for essential hypertension.
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: Efficacy and Safety of Weak Extremely Low Frequency Electromagnetic Fields in Mild and Moderate Essential Hypertension [Phase 2]
This Phase 2 trial evaluating the efficacy and safety of exposure to weak extremely low frequency electromagnetic fields in adults with mild…
-
CLINICAL_TRIALS trial_result · 2009-01-05Clinical Trial Update: Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential Hypertension [Phase 4]
Phase 4 trial update comparing awakening versus bedtime dosing of aspirin in people with high-normal blood pressure or mild essential hypert…
-
CLINICAL_TRIALS trial_result · 2008-12-17Clinical Trial Update: A Dose-Ranging Study of the Safety and Efficacy of ADX415 in the Treatment of Essential Hypertension [Phase 2]
Phase 2 dose-ranging study evaluating the safety and efficacy of ADX415 in essential hypertension has completed.
-
FDA approval · 2008-10-29FDA Approved: TENORETIC — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for TENORETIC (atenolol and chlorthalidone) from Upsher-Smith Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2008-09-12Clinical Trial Update: Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly [Phase 3]
A Phase 3 trial comparing olmesartan medoxomil with losartan in elderly patients with essential hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2008-07-17Clinical Trial Update: Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients [Phase 4]
Phase 4 clinical trial comparing valsartan plus amlodipine vs losartan plus amlodipine in adults with essential hypertension; no results are…
-
FDA approval · 2008-05-19FDA Approved: ALISKIREN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for aliskiren hemifumarate by Prasco Laboratories to market the generic product.
-
CLINICAL_TRIALS trial_result · 2008-05-09Clinical Trial Update: The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension [Phase 4]
Phase 4 trial investigates how eprosartan affects hormones and kidney function in people with essential hypertension.
-
CLINICAL_TRIALS trial_result · 2008-04-29Clinical Trial Update: Olmesartan in Essential Hypertension [Phase 3]
A Phase 3 trial evaluating olmesartan for essential hypertension has been completed.
-
CLINICAL_TRIALS trial_result · 2008-04-16Clinical Trial Update: Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left Ventricular [Phase 3]
Phase 3 trial evaluating the effects of losartan on myocardial structure in patients with essential hypertension and diabetes mellitus.